4.8 Article

Partial DNA-guided Cas9 enables genome editing with reduced off-target activity

期刊

NATURE CHEMICAL BIOLOGY
卷 14, 期 3, 页码 311-+

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEMBIO.2559

关键词

-

资金

  1. National Institutes of Health (NIH) [5R00CA169512, DP2HL137167, P01HL131471]
  2. NIH [5-U54-CA151884-04, P30-CA14051]
  3. Skoltech Center
  4. Lung Cancer Research Foundation
  5. Hyundai Hope on Wheels
  6. ALS Association
  7. NATIONAL CANCER INSTITUTE [R00CA169512] Funding Source: NIH RePORTER
  8. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [DP2HL137167, P01HL131471] Funding Source: NIH RePORTER

向作者/读者索取更多资源

CRISPR-Cas9 is a versatile RNA-guided genome editing tool. Here we demonstrate that partial replacement of RNA nucleotides with DNA nucleotides in CRISPR RNA (crRNA) enables efficient gene editing in human cells. This strategy of partial DNA replacement retains on-target activity when used with both crRNA and sgRNA, as well as with multiple guide sequences. Partial DNA replacement also works for crRNA of Cpf1, another CRISPR system. We find that partial DNA replacement in the guide sequence significantly reduces off-target genome editing through focused analysis of off-target cleavage, measurement of mismatch tolerance and genome-wide profiling of off-target sites. Using the structure of the Cas9-sgRNA complex as a guide, the majority of the 3' end of crRNA can be replaced with DNA nucleotide, and the 5 - and 3'-DNA-replaced crRNA enables efficient genome editing. Cas9 guided by a DNA-RNA chimera may provide a generalized strategy to reduce both the cost and the off-target genome editing in human cells.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据